Protein tyrosine phosphatases and the immune response

Nature Reviews Immunology

Volumn 5, Issue 1, 2005, Pages 43-57

  Mustelin, Tomas ^a   Vang, Torkel ^a   Bottini, Nunzio ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE;

B LYMPHOCYTE; CATALYSIS; EUKARYOTE; GENE; GENOME; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PTP GENE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD45; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNITY; LYMPHOCYTES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 11244277091     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1530     Document Type: Review

References (139)

1. Hunter, T. & Sefton, B. M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl Acad. Sci. USA 77, 1311-1315 (1980).
2. Mustelin, T., Abraham, R. T., Rudd, C. E., Alonso, A. & Merlo, J. J. Protein tyrosine phosphorylation in T cell signaling. Front. Biosci. 7, 918-969 (2001).
3. Mustelin, T. Src Family Tyrosine Kinases in Leukocytes 1-155 (Landes, Austin, 1994).
4. Mustelin, T., Rahmouni, S., Bottini, N. & Alonso, A. Role of protein tyrosine phosphatases in T cell activation. Immunol. Rev. 192, 139-147 (2003).
5. Mustelin, T. & Taskén, K. Positive and negative regulation of T cell activation through kinases and phosphatases. Biochem. J. 371, 15-27 (2003).
6. Alonso, A. et al. Protein tyrosine phosphatases in the human genome. Cell 117, 699-711 (2004). This paper reviews the entire complement of 107 PTP genes in the human genome.
7. Andersen, J. N. et al. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J. 18, 8-13 (2004).
8. Samelson, L. E., Patel, M. D., Weissman, A. M., Harford, J. B. & Klausner, R. D. Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor. Cell 46, 1083-1090 (1986).
9. Hsi, E. D. et al. T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J. Biol. Chem. 264, 10836-10842 (1989).
10. Mustelin, T., Coggeshall, K. M., Isakov, N. & Altman, A. Tyrosine phosphorylation is required for T cell antigen receptor-mediated activation of phospholipase C. Science 247, 1584-1587 (1990).
11. Saltzman, E. M., Thom, R. R. & Casnellie, J. E. Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2. J. Biol. Chem. 263, 6956-6959 (1988).
12. Gold, M. R., Matsuuchi, L., Kelly, R. B. & DeFranco, A. L. Tyrosine phosphorylation of components of the B cell antigen receptors following receptor crosslinking. Proc. Natl Acad. Sci. USA 88, 3436-3440 (1991).
13. Mustelin, T. T cell antigen receptor signaling: three families of tyrosine kinases and a phosphatase. Immunity 1, 351-356 (1994).
14. Weiss, A. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73, 209-212 (1993).
15. Mustelin, T. et al. Protein tyrosine phosphatases. Front. Biosci. 7, 85-142 (2002).
16. Iivanainen, A. V., Lindqvist, C., Mustelin, T. & Andersson, L. C. Phosphotyrosine phosphatases are involved in reversion of T lymphoblastic proliferation. Eur. J. Immunol. 20, 2509-2512 (1990).
17. O'Shea, J. J., McVicar, D. W., Bailey, T. L., Burns, C. & Smyth, M. J. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc. Natl Acad. Sci. USA 89, 10306-10310 (1992).
18. Secrist, J. P., Burns, L. A., Karnitz, L., Koretzky, G. A. & Abraham, R. T. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268, 5886-5893 (1993). References 17 and 18 were the first papers to show that acute inhibition of PTPs is sufficient to cause T-cell activation.
19. Oetken., C. et al. Phenylarsine oxide augments tyrosine phosphorylation in hematopoietic cells. Eur. J. Haematol. 49, 208-214 (1992).
20. Earp, H. S., Austin, K. S., Buessow, S. C. & Gillespie, G. Y. Membranes from T and B lymphocytes have different patterns of tyrosine phosphorylation. Proc. Natl Acad. Sci. USA 81, 2347-2351 (1984).
21. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912-1934 (2002).
22. Gjörloff-Wingren, A. et al. Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur. J. Immunol. 30, 2412-2421 (2000).
23. Gjörloff-Wingren, A., Saxena, M., Williams, S., Hammi, D. & Mustelin, T. Characterization of TCP-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 29, 3845-3854 (1999).
24. Han, S., Williams, S. & Mustelin, T. Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling. Eur. J. Immunol. 30, 1318-1325 (2000).
25. Bottini, N. et al. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J. Biol. Chem. 277, 24220-24224 (2002).
26. Townley, P., Shen, S.-H., Banville, D. & Ramachandran, C. Inhibition of the activity of protein tyrosine phosphatase 1C by its SH2 domains. Biochemistry 32, 13414-13418 (1993).
27. Pei, D., Lorenz, U., Klingmüller, U., Neel, B. G. & Walsh, C. T. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: a new function for Src homology 2 domains. Biochemistry 33, 15483-15493 (1994).
28. Zhao, Z., Larocque, R., Ho, W.-T., Fischer, E. H. & Shen, S.-H. Purification and characterization of PTP2C, a widely distributed protein tyrosine phosphatase containing two SH2 domains. J. Biol. Chem. 269, 8780-8785 (1994).
29. Pei, D., Wang, J. & Walsh, C. T. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proc. Natl Acad. Sci. USA 93, 1141-1145 (1996).
30. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J. & Shoelson, S. E. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450 (1998).
31. Alonso, A. et al. VHY, a novel, myristoylated testis-restricted dual specificity protein phosphatase related to VHX. J. Biol. Chem. 279, 32586-32591 (2004).
32. lck by the CD45 phosphotyrosine phosphatase. Proc. Natl Acad. Sci. USA 86, 6302-6306 (1989). This paper was the first to show that the PTP CD45 can activate the PTK LCK by direct dephosphorylation.
33. lck by the leukocyte common antigen (CD45). Oncogene 5, 809-813 (1990).
34. lyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 22, 1173-1178 (1992).
35. Brockdorff, J., Williams, S., Couture, C. & Mustelin, T. Dephosphorylation of ZAP-70 and inhibition of T cell activation by activated SHP1. Eur. J. Immunol. 29, 2539-2550 (1999).
36. c-src by overexpression of a protein tyrosine phosphatase. Nature 359, 336-339 (1992).
37. Mustelin, T. & Hunter, T. Meeting at mitosis: cell cycle-specific regulation of c-Src by RPTPα. Sci. STKE [online] 2002, PE3 (2002).
38. Salmeen, A. et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423, 769-773 (2003).
39. van Montfort, R. L. M., Congreve, M., Tisi, D., Carr, R. & Jhoti, H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423, 773-777 (2003). References 38 and 39 report the crystallization of oxidized PTP1B and reveal that oxidation of the catalytic cysteine residue results in the formation of a sulphenyl amide moiety, which is resistant to further oxidation (which would be irreversible) and can be reduced back to the catalytically active free cysteinyl.
40. Meng, T.-C., Buckley, D. A., Galic, S., Tiganis, T. & Tonks, N. K. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J. Biol. Chem. 279, 37716-37725 (2004).
41. Wang, X. et al. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase. J. Immunol. 164, 1934-1939 (2000).
42. Qu, C.-K., Nguyen, S., Chen, J. & Feng, G.-S. Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood 97, 911-914 (2001).
43. Kishihara, K. et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74, 143-156 (1993).
44. Gronda, M., Arab, S., Iafrate, B., Suzuki, H. & Zanke, B. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Mol. Cell. Biol. 21, 6851-6858 (2001).
45. Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548 (1999).
46. You-Ten, K. E. et al. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J. Exp. Med. 186, 683-693 (1997).
47. Charbonneau, H., Tonks, N. K., Walsh, K. A. & Fischer, E. H. Tine leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc. Natl Acad. Sci. USA 85, 7182-7186 (1988).
48. Tonks, N. K., Charbonneau, H., Diltz, C. D., Fischer, E. H. & Walsh, K. A. Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 27, 8695-8701 (1988). Although reference 47 was the first to report that CD45 has a high degree of homology with the first identified PTP, PTP1B, and therefore was likely to be a PTP itself, reference 48 directly showed this by providing evidence that CD45 has tyrosine-phosphatase activity.
49. Pingel, J. T. & Thomas, M. L. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58, 1055-1065 (1989). This paper was the first to show that expression of CD45 is important for T-cell activation.
50. Hermiston, M. L., Xu, Z. & Weiss, A. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21, 107-137 (2003).
51. Koretzky, G. A., Picus, J., Thomas, M. L. & Weiss, A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 346, 66-68 (1990).
52. 2+ oscillations. J. Exp. Med. 176, 835-844 (1992).
53. Ostergaard, H. L. et al. Expression of CD45 alters phosphorylation of the Lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc. Natl Acad. Sci. USA 86, 8959-8963 (1989).
54. lck Y505F mutation in CD45-deficient mice rescues thymocyte development. Mol. Cell. Biol. 19, 4200-4208 (1999).
55. Mustelin, T. & Burn, P. Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem. Sci. 18, 215-220 (1993).
56. Davidson, D., Bakinowski, M., Thomas, M. L., Horejsi, V. & Veillette, A. Phosphorylation-dependent regulation of T cell actuation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol. Cell. Biol. 23, 2017-2025 (2003).
57. Kawabuchi, M. et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404, 999-1003 (2000).
58. Brdicka, T. et al. Phosphoprotein associated with glycosphingolipid- enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adapter protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation. J. Exp. Med. 191, 1591-1604 (2000).
59. Torgersen, K. M. et al. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J. Biol. Chem. 276, 29313-29318 (2001).
60. Vang, T., Abrahamsen, H., Myklebust, S., Horejsi, V. & Taskén, K. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase A inhibits T cell receptor signaling. J. Biol. Chem. 278, 17597-17604 (2003).
61. Vang, T. et al. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells. Eur. J. Immunol. 34, 2191-2199 (2004).
62. Zhang, S. Q. et al. Shp2 regulates Src family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol. Cell 13, 341-351 (2004).
63. Ledbetter, J. A., Tonks, N. K., Fischer, E. H. & Clark, E. A. CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc. Natl Acad. Sci. USA 85, 8628-8633 (1988).
64. Kiener, P. A. & Mittler, R. S. CD45-protein tyrosine phosphatase cross-linking inhibits T cell receptor CD3-mediated activation in human T cells. J. Immunol. 143, 23-28 (1989).
65. lck. J. Exp. Med. 172, 347-350 (1990).
66. Volarevic, S. et al. Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains. Science 260, 541-544 (1993).
67. Furukawa, T., Itoh, M., Krueger, N. X., Streuli, M. & Saito, H. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine phosphorylated CD3 ζ chain. Proc. Natl Acad. Sci. USA 91, 10928-10932 (1994).
68. zap tyrosine protein kinase by the CD45 phosphotyrosine phosphatase in T cells. Eur. J. Immunol. 25, 942-946 (1995).
69. D'Oro, U., Sakaguchi, K., Appella, E. & Ashwell, J. D. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol. Cell. Biol. 16, 4996-5003 (1996).
70. Katagiri, T. et al. CD45 negatively regulates Lyn activity by dephosphorylating both positive and negate regulatory tyrosine residues in immature B cells. J. Immunol. 163, 1321-1330 (1999).
71. He, X., Woodford-Thomas, T. A., Johnson, K. G., Shah, D. D. & Thomas, M. L. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling. Eur. J. Immunol. 32, 2578-2584 (2002).
72. Montixi, C. et al. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 17, 5334-5340 (1998).
73. Edmonds, S. D. & Ostergaard, H. L. Dynamic association of CD45 with detergent-insoluble microdomains in T lymphocytes. J. Immunol. 169, 5036-5046 (2002).
74. Iries, C. et al. CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nature Immunol. 4, 189-192 (2003).
75. Freiberg, B. A. et al. Staging and resetting T cell activation in SMACs. Nature Immunol. 3, 911-916 (2002).
76. Majeti, R., Bilwes, A. M., Noel, J. P., Hunter, T. & Weiss, A. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279, 88-91 (1998).
77. Majeti, R. et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103, 1059-1069 (2000).
78. Xu, Z. & Weiss, A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nature Immunol. 3, 764-770 (2002).
79. Dianzani, U. et al. Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur. J. Immunol. 22, 365-371 (1992).
80. Matthews, R. J., Bowne, D. B., Flores, E. & Thomas, M. L. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol. Cell. Biol. 12, 2396-2405 (1992).
81. Vivier, E. & Daëron, M. Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 18, 286-291 (1997).
82. Mustelin, T. et al. T cell activation: the coming of the phosphatases. Front. Biosci. 3, D1060-D1096 (1998).
83. Chiang, G. G. & Sefton, B. M. Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 276, 23173-23179 (2001).
84. LCK phosphorylation and ZAP-70 binding to T cell receptor ζ chain. Biochem. Biophys. Res. Commun. 222, 50-57 (1996).
85. Tsui, H. W., Siminovitch, K. A., de Souza, L. & Tsui, F. W. L. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet. 4, 124-129 (1993).
86. Shultz, L. D. & Green, M. C. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J. Immunol. 116, 936-943 (1976).
87. Pani, G., Fischer, K.-D., Mlinaric-Rascan, I. & Siminovitch, K. A. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184, 839-852 (1996).
88. Sathish, J. G. et al. CD22 is a functional ligand for SHP1 in primary T cells. J. Biol. Chem. 279, 47783-47791 (2004).
89. Roy, G., Matthews, J., Woodford-Thomas, T. & Thomas, M. L. The function of protein tyrosine phosphatases in immune regulation. Adv. Protein Phosphatases 9, 121-138 (1995).
90. csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15, 4909-4918 (1996).
91. Cloutier, J.-F. & Veillette, A, Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 189, 111-121 (1999). References 90 and 91 document the high-stoichiometry association between the PEP phosphatase and the inhibitory kinase CSK. The papers conclude that the interaction between the two enzymes helps PEP reach its SRC-family PTK targets.
92. Cohen, S., Dadi, H., Shaoul, E., Sharfe, N. & Roifman, C. M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93, 2013-2024 (1999).
93. Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nature Genet. 36, 337-338 (2004). This paper reports that a single amino-acid substitution at position 620 of the human PTP LYP is sufficient to cause a marked increase in the incidence of type 1 diabetes. This increase correlates with a loss of association with CSK.
94. Begovich, A. B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330-337 (2004).
95. Kyogoku, C. et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75, 504-507 (2004).
96. Smyth, D. et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53, 3020-3023 (2004).
97. -/- mice.
98. csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J. Biol. Chem. 272, 23455-23462 (1997).
99. Wang, B., Lemay, S., Tsai, S. & Veillette, A. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF. Mol. Cell. Biol. 21, 1077-1088 (2001).
100. Cote, J. F., Charest, A., Wagner, J. & Tremblay, M. L. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model. Biochemistry 37, 13128-13137 (1998).
101. cas as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol. Cell. Biol. 16, 6408-6418 (1996).
102. Davidson, D. & Veillette, A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J. 20, 3414-3426 (2001).
103. Spencer, S. et al. PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J. Cell Biol. 138, 845-860 (1997).
104. Sozio, M. S. et al. PTPH1 is a predominant protein-tyrosine phosphatase capable of interacting with and dephosphorylating the T cell receptor ζ subunit. J. Biol. Chem. 279, 7760-7768 (2004).
105. Zhang, S.-H., Liu, J., Kobayashi, R. & Tonks, N. K. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 274, 17806-17812 (1999).
106. Egerton, M. et al. VCP, the mammalian homolog of CDC48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J. 11, 3533-3540 (1992).
107. Lavoie, C. et al. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc. Natl Acad. Sci. USA 97, 13637-13642 (2000).
108. Zheng, Y., Schlondorff, J. & Biobel, C. P. Evidence for regulation of the tumor necrosis factor α-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 277, 42463-42470 (2002).
109. Tailor, P., Williams, S., Gilman, J., Couture, C, & Mustelin, T. Regulation of the low molecular weight phosphotyrosine phosphatase (LMPTP) by phosphorylation at tyrosines 131 and 132. J. Biol. Chem. 272, 5371-5376 (1997).
110. Alonso, A., Saxena, M., Williams, S. & Mustelin, T. Inhibitory role for dual-specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J. Biol. Chem. 276, 4766-4771 (2001).
111. Alonso, A. et al. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nature Immunol. 4, 44-48 (2003).
112. Saxena, M. & Mustelin, T. Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin. Immunol. 12, 387-396 (2000).
113. Saxena, M., Williams, S., Gilman, J. & Mustelin, T. Negative regulation of T cell antigen receptor signaling by hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 273, 15340-15344 (1998).
114. Saxena, M., Williams, S., Brockdorff, J., Gilman, J. & Mustelin, T. Inhibition of T cell signaling by MAP kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 274, 11693-11700 (1999).
115. Saxena, M., Williams, S., Taskén, K. & Mustelin, T. Crosstalk between cAMP-dependent kinase and MAP kinase through hematopoietic protein tyrosine phosphatase (HePTP). Nature Cell Biol. 1, 305-311 (1999).
116. Nika, K. et al. Hematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T cells: dynamics and subcellular location. Biochem. J. 378, 335-342 (2004).
117. Klingmüller, U., Lorenz, U., Cantley, L. C., Neel, B. G. & Lodish, H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729-738 (1995).
118. Myers, M. P. et al. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276, 47771-47774 (2001).
119. ten Hoeve, J. et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22, 5662-5668 (2002).
120. Zhu, W., Mustelin, T. & David, M. Arginine methylation of STAT1 regulates its dephosphorylation by TcPTP. J. Biol. Chem. 277, 35787-35790 (2002).
121. Wang, X. et al. Enlargement of secretory vesicles by protein tyrosine phosphatase PTP-MEG2 in RBL mast cells and Jurkat T cells. J. Immunol. 168, 4612-4619 (2004).
122. Huynh, H. et al. Homotypic secretory vesicle fusion induced by the protein tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells. J. Immunol. 171, 6661-6671 (2003).
123. Huynh, H. et al. Control of vesicle fusion by a tyrosine phosphatase. Nature Cell Biol. 6, 831-839 (2004).
124. Matsushita, M., Tsuchiya, N., Oka, T., Yamane, A. & Tokunaga, K. New variations of human SHP-1. Immunogenetics 49, 577-579 (1999).
125. Jury, E. C., Kabouridis, P. S., Flores-Borja, F., Mageed, R. A. & Isenberg, D. A. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 113, 1176-1187 (2004).
126. Tchilian, E. Z. et al. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J. Immunol. 166, 1308-1313 (2001).
127. Jacobsen, M. et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nature Genet. 26, 495-499 (2000).
128. Barcellos, L. F. et al. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Nature Genet. 29, 23-24 (2001).
129. Vorechovsky, I. et al. Does 77C→G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nature Genet. 29, 22-23 (2001).
130. Bottini, N., Bottini, E., Gloria-Bottini, F. & Mustelin, T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch. Immunol. Ther. Exp. (Warsz.) 50, 95-104 (2002).
131. Bottini, N. et al. Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. Clin. Genet. 63, 228-231 (2003).
132. Cornelis, G. R. & Wolf-Watz, H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23, 861-867 (1997).
133. Andersson, K. et al. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol. Microbiol. 20, 1057-1069 (1996).
134. Yao, T., Mecsas, J., Healy, J. I., Falkow, S. & Chien, Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, YopH. J. Exp. Med. 190, 1343-1350 (1999).
135. Alonso, A. et al. Lck dephosphorylation at Y394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. J. Biol. Chem. 279, 4922-4928 (2004). References 134 and 135 show that the phosphatase YopH from Yersinia spp. is a potent inhibitor of T-cell activation. Reference 135 shows that the molecular mechanism of inhibition involves the dephosphorylation of Y394 of LCK, resulting in complete abrogation of signalling through the TCR.
136. Murli, S., Watson, R. O. & Galan, J. E. Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell. Microbiol. 3, 795-810 (2001).
137. Singh R. et al. Disruption of MptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol. Microbiol. 50, 751-762 (2003).
138. Lazo, J. S. & Wipf, P. Small molecule regulation of phosphatase-dependent cell signaling pathways. Oncol. Res. 13, 347-352 (2003).
139. Liang, F. et al. Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of the plague. J. Biol. Chem. 278, 41734-41741 (2003).